Actively Recruiting
Study of JKN2301 Dry Suspension to Treat Influenza in Children Aged 2 to Under 12 Years Phase III Trial Comparing Safety and Effectiveness with Oseltamivir
Led by Joincare Pharmaceutical Group Industry Co., Ltd · Updated on 2026-01-21
177
Participants Needed
1
Research Sites
10 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the safety, pharmacokinetics, and effectiveness of JKN2301 Dry Suspension in treating uncomplicated influenza in children aged 2 to 11 years. This phase III study compares JKN2301 with Oseltamivir and aims to understand how well JKN2301 works for influenza in pediatric patients. The study is sponsored by Joincare Pharmaceutical Group Industry Co., Ltd and focuses on early treatment during the symptomatic phase of influenza. Participants are randomly assigned to receive either a single oral dose of JKN2301 Dry Suspension with a placebo matching Oseltamivir or an oral suspension of Oseltamivir twice daily for 5 days with a placebo matching JKN2301. The dosing is based on weight tiers for both treatments. The study is double-blind and double-dummy, ensuring participants and researchers do not know which treatment is given. Treatment effects and safety are monitored closely throughout the study. During the study, participants will be monitored from baseline through Day 15 for adverse events, physical exams, vital signs, lab tests, and ECGs. Researchers will measure influenza symptom relief, fever duration, viral shedding, viral load changes, and complications up to Day 15. Plasma levels of JKN2301 and metabolites will be assessed up to Day 6. The total participation includes treatment and follow-up visits to assess safety and treatment outcomes.
CONDITIONS
Brief Title
Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
Research Team
Y
Ying Yang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here